🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y Seiwert, Barbara Burtness et al. (2016)

The Lancet Oncology

1.6K citesjournal articlePDF

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl et al. (2010)

Journal of Clinical Oncology

1.6K citesjournal articlePDF

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

Priya Rastogi, Stewart J. Anderson et al. (2008)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

Robert J. Motzer, Madhu Mazumdar et al. (1999)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L Coleman, Amit M Oza et al. (2017)

The Lancet

1.5K citesjournal articlePDF

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

Jean-Yves Douillard, Salvatore Siena et al. (2010)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis

S. Popat, R. Hubner et al. (2005)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Christopher M Nutting, James P Morden et al. (2011)

The Lancet Oncology

1.5K citesjournal articlePDF

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A. Cervantes, R. Adam et al. (2023)

Annals of Oncology

1.7K citesjournal articlePDF

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

A.S. Coates, E.P. Winer et al. (2015)

Annals of Oncology

1.5K citesjournal articlePDF

Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

Ramaswamy Govindan, Nathan Page et al. (2006)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer

Yan-qi Huang, Chang-hong Liang et al. (2016)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

M.E.R. O’Brien, N. Wigler et al. (2004)

Annals of Oncology

1.5K citesjournal articlePDF

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

B Fisher, A Brown et al. (1997)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Use of Normal Tissue Complication Probability Models in the Clinic

Lawrence B. Marks, Ellen D. Yorke et al. (2010)

International Journal of Radiation Oncology*Biology*Physics

1.5K citesjournal articlePDF